论文部分内容阅读
Renal tubulointerstitial fibrosis is the common ending of progressive renal disease. It is worth developing new ways to stop the progress of renal fibrosis. Peroxisome proliferator-activated receptor-γ(PPARγ) agonists have been studied to treat diabetic n